Physician profile
John Wickman
NPI 1609372499
$8,257.15
in general payments reported to CMS, 2019-2025
7 companies · $402 in 2025
The $402 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,400 · 2022: $660 · 2023: $2,256 · 2024: $2,539 · 2025: $402.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,900 · Travel and Lodging: $2,296.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,900.45 |
| Travel and Lodging | $2,296.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,759.38 | 2022-2025 | Blueprint Patient Specific Instrumentation, Aequalis Perform, Aequalis Perform Reversed |
| Southtech Orthopedics | $2,400.00 | 2021 | |
| Encore Medical, LP | $1,458.93 | 2023 | Djo Surgical |
| Core Surgical Group | $317.23 | 2024-2025 | |
| Acumed LLC | $113.04 | 2024 | Acumed, Innate Implant |
| Illuminoss Medical, INC. | $104.47 | 2023 | Photodynamic Bone Stabilization Procedure Pack |
| Depuy Synthes Sales INC. | $104.10 | 2023-2025 | Attune, Inhance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Wickman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.